BRAINSWAY LTD/S (NASDAQ:BWAY) Trading Up 17%

Share on StockTwits

BRAINSWAY LTD/S (NASDAQ:BWAY) shares were up 17% during trading on Monday . The stock traded as high as $11.24 and last traded at $10.80, approximately 187,875 shares were traded during trading. An increase of 1,565% from the average daily volume of 11,283 shares. The stock had previously closed at $9.23.

BWAY has been the subject of several analyst reports. Raymond James lowered their price objective on BRAINSWAY LTD/S from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Tuesday, November 26th. Zacks Investment Research cut BRAINSWAY LTD/S from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $15.60.

The company has a 50-day moving average price of $8.99 and a 200-day moving average price of $9.73.

Several large investors have recently added to or reduced their stakes in the company. Victory Capital Management Inc. acquired a new position in shares of BRAINSWAY LTD/S during the 2nd quarter worth about $157,000. Noked Capital LTD acquired a new position in shares of BRAINSWAY LTD/S during the 2nd quarter worth about $572,000. ARK Investment Management LLC acquired a new position in shares of BRAINSWAY LTD/S during the 2nd quarter worth about $863,000. Delek Group Ltd. acquired a new position in shares of BRAINSWAY LTD/S during the 2nd quarter worth about $3,176,000. Finally, Phoenix Holdings Ltd. acquired a new position in shares of BRAINSWAY LTD/S during the 3rd quarter worth about $2,694,000. 14.11% of the stock is owned by institutional investors and hedge funds.

About BRAINSWAY LTD/S (NASDAQ:BWAY)

Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. It offers deep transcranial magnetic stimulation systems for treating various conditions, including autism, Alzheimer's disease, bipolar disorders, chronic pains, depressive disorders, Parkinson's diseases, schizophrenia, smoking cessation, post-traumatic stress disorders, multiple sclerosis, obsessive compulsive disorders, and stroke rehabilitation.

Further Reading: Stocks Increasing Dividends

Receive News & Ratings for BRAINSWAY LTD/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BRAINSWAY LTD/S and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.